Range Financial Group LLC Abb Vie Inc. Transaction History

Range Financial Group LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $29,410 - $34,344	-190 Reduced 1.34%	13,972 $2.4 Million
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $40,594 - $46,253	254 Added 1.83%	14,162 $2.58 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $221,398 - $249,346	-1,609 Reduced 10.37%	13,908 $2.16 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $44,752 - $51,807	-335 Reduced 2.11%	15,517 $2.31 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $1.31 Million - $1.63 Million	-9,863 Reduced 38.36%	15,852 $2.14 Million
Q1 2023 Apr 03, 2023	SELL	$144.61 - $166.54 $71,871 - $82,770	-497 Reduced 1.9%	25,715 $4.1 Million
Q4 2022 Jan 13, 2023	BUY	$138.31 - $165.87 $83,539 - $100,185	604 Added 2.36%	26,212 $0
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $451,482 - $517,820	-3,364 Reduced 11.61%	25,608 $3.44 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $122,206 - $155,364	-888 Reduced 2.97%	28,972 $4.44 Million
Q1 2022 May 18, 2022	SELL	$131.98 - $163.75 $32,467 - $40,282	-246 Reduced 0.82%	29,860 $4.84 Million
Q4 2021 Jul 11, 2022	BUY	$107.43 - $135.93 $38,674 - $48,934	360 Added 1.21%	30,106 $4.08 Million
Q3 2021 Jul 11, 2022	BUY	$106.4 - $120.78 $53,944 - $61,235	507 Added 1.73%	29,746 $3.21 Million
Q2 2021 Jul 11, 2022	BUY	$105.21 - $117.21 $203,265 - $226,449	1,932 Added 7.08%	29,239 $3.29 Million
Q1 2021 Jul 11, 2022	BUY	$102.3 - $112.62 $2.79 Million - $3.08 Million	27,307 New	27,307 $2.96 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Range Financial Group LLC with notifications on news.